Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressants to prevent relapse in depression in adults aged 75 years and over
ISRCTN26190474Phase 4Active, not recruiting
- Sponsor
- University College London
- Start
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of citalopram, sertraline and mirtazapine in major depressive disorder (MDD), sponsored by University College London. Primary endpoint: Time to first relapse of depression. Started Nov 2024; status: active, not recruiting.
02
Drugs
citalopramsertralinemirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN26190474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26190474.